Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Endpoints not met, but data provides insights to Alzheimer’s pathobiology
CRS programme to feature Poolbeg Pharma trial
ChemLex raises $45m and launches lab for drug discovery in Singapore
Potent and selective antitumour activity in acute myeloid leukaemia study
Positive results from male and female infertility monoclonal antibody trial
Positive results from ALS study
EspeRare receives Gates Foundation grant to advance preeclampsia novel therapy
CRO Avetra launched